Selected Scientific Presentations
Since 2020
2021
20. Deutscher Kongress für Versorgungsforschung (DKVF)
Berlin / Germany, October 06-08, 2021:
Impact of the corona pandemic on cancer patients: Results from a German cross-sectional pilot study.
(Poster Presentation available on request)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (DGHO)
Hybrid Event, Berlin / Germany, October 01-04, 2021:
Online survey of cancer patients on changes in care and on psycho-social burden during the pandemic.
(Poster Presentation available on request)
2020
International Society for Pharmacoeconomics & Outcomes Research (ISPOR)
Virtual ISPOR Europe, November 16 – November 19, 2020:
Social Cost Value Analysis: Do we need an alternative health economic evaluation paradigm?
(Online Panel Session)
Conference proceedings from Virtual ISPOR Europe 2020.
The acquisition cost and efficiency of CAR T-cell therapies: can they be improved by decentralized manufacturing?
(Online Research Poster Presentation)
Value in Health (2020), 23(S2): S460.
The role of the budget impact: A multivariate analysis of health technology assessment (HTA) outcomes by GBA/IQWiG in Germany and NICE in England.
(Online Research Poster Presentation)
Value in Health (2020), 23(S2): S530.
How much does it cost to research & develop a new drug? A systematic review and evaluation of 40 years of literature.
(Online Research Poster Presentation)
Value in Health (2020), 23(S2): S756.
A systematic review of the socioeconomic impact of cancer on patients and families: Are differences among countries being effectively captured and addressed?
(Online Research Poster Presentation)
Value in Health (2020), 23(S2): S478.
Modeling the duration of protective effects and resource use of colonoscopy screening by a discrete event simulation model calibrated with German screening registry data.
(Online Research Poster Presentation)
Value in Health (2020), 23(S2): S456-457.
German, Austrian and Swiss Associations of Hematology and Medical Oncology (DGHO)
October 09 – October 11, 2020:
Direct and indirect cost of malignant cutaneous melanoma in European countries – Results of a literature review.
(Abstract Video Presentation)
DGHO Annual Meeting 2020.
European Society for Medical Oncology (ESMO)
ESMO Virtual Congress, September 19 – September 21, 2020:
Can we reduce the acquisition cost of CAR T-cell therapies?
(Online Research Poster Presentation)
Annals of Oncology (2020), 31(S4): S966.
Health technology assessment (HTA) in England, France and Germany: What do we know about variations in cancer-related HTA outcomes?
(Online Presentation)
Annals of Oncology (2020), 31(S4): S1197.
How much does it cost to research and develop a new medicine? A systematic review and evaluation of 40 years of literature.
(Online Research Poster Presentation)
Annals of Oncology (2020), 31(S4): S962.
Modelling the long-term effectiveness of colonoscopy screening by a discrete event simulation model calibrated with German screening registry data.
(Online Research Poster Presentation)
Annals of Oncology (2020), 31(S4): S457-458.
International Society for Pharmacoeconomics & Outcomes Research (ISPOR)
Virtual ISPOR, May 18 – May 20, 2020:
´Advancing evidence to action´: A comparison of health technology assessment (HTA) outcomes in England, France and Germany.
(Online Research Poster Presentation)
Value in Health (2020), 23(S1): S70.
Income loss after a cancer diagnosis in Germany: an analysis based upon the socio-economic panel survey.
(Online Research Poster Presentation)
Value in Health (2020), 23(S1): S76.
The social and socioeconomic impact ofcancer on patients and their families: A systematic review.
(Online Research Poster Presentation)
Value in Health (2020), 23(S1): S78.